Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone replacement therapy helps manage deficiency and has various methods, but requires careful monitoring to avoid side effects.

Cyproterone helps women with hair loss caused by genetics. More research is needed to confirm the best dose.

A specific metabolite, not a receptor protein, triggers the production of certain kidney enzymes, but this process is disrupted in mice with a mutation causing testicular feminization.

Estradiol and castration reduced prostate cancer development in rats when applied at early stages, but were ineffective after cancer was established.

Only anti-androgenic drugs likely halt AGA progression.

Certain peptides, caffeine, taurine, and an iron complex may improve hair regrowth when used with minoxidil and finasteride for hair loss.

The document concludes that hair transplantation and gene therapy may be important for future hair loss treatment.

Combination therapy significantly reduces testosterone and moderately reduces hair growth in women with hirsutism.

A 15-year-old girl with rare reproductive disorders received hormone therapy to develop secondary sexual traits, but infertility persisted.

Smart microneedles improve hair loss treatment by delivering drugs precisely with fewer side effects.

Hair loss can be treated with common methods like minoxidil and finasteride, but new potential treatments include growth factors, cytokines, and platelet-rich plasma injections.

Cyproterone acetate is used for topical treatment of diseases dependent on male hormones.

GI197111X is best dissolved in Capmul MCM for trials.

Australian dermatologists often prescribe spironolactone and minoxidil for female hair loss.

A new treatment using probiotic microneedles shows promise for promoting hair growth and reducing inflammation in androgenetic alopecia.

Combination therapies for androgenetic alopecia are more effective, but more research is needed for safe, standardized treatments.

Hormonal treatments effectively treat acne in females and could reduce antibiotic use.

A new hair loss treatment uses tiny needles to deliver a drug-loaded lipid carrier, promoting hair growth more effectively than current treatments.

The effect of GLP-1 RAs on erectile function is unclear and needs more research.

Combining dutasteride mesotherapy with oral minoxidil is more effective for hair loss than using oral minoxidil alone.

New research is needed to create better drugs that block the enzyme responsible for conditions like male baldness and prostate enlargement.

Targeting the PGD2-DP2 pathway may help treat hair loss.

Inhibiting testosterone 5alpha-reductase may help treat benign prostatic hyperplasia.

Androgenetic alopecia, a genetic disorder affecting up to 50% of adults, is caused by an excessive response to androgens leading to hair follicle shrinkage. Treatments include FDA-approved drugs, other therapies like low-dose oral minoxidil, and hair transplantation.

Botulinum neurotoxin injections into the pelvic muscles successfully prevented priapism relapse for over six months.

Some off-label treatments may be effective for male pattern baldness.

Current and new treatments for hair loss include topical minoxidil and oral finasteride, but results vary and new options are being explored.

SARMs show promise but need more evidence to prove they're better than traditional androgens.